A detailed history of Janus Henderson Group PLC transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 4,076,020 shares of IDYA stock, worth $124 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
4,076,020
Previous 3,808,450 7.03%
Holding current value
$124 Million
Previous $167 Million 14.36%
% of portfolio
0.08%
Previous 0.09%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$34.37 - $43.46 $9.2 Million - $11.6 Million
267,570 Added 7.03%
4,076,020 $143 Million
Q1 2024

May 15, 2024

BUY
$34.2 - $47.13 $8.77 Million - $12.1 Million
256,559 Added 7.22%
3,808,450 $167 Million
Q4 2023

Feb 14, 2024

BUY
$24.59 - $35.83 $45 Million - $65.5 Million
1,828,731 Added 106.13%
3,551,891 $126 Million
Q3 2023

Nov 14, 2023

BUY
$21.07 - $29.77 $1.17 Million - $1.66 Million
55,637 Added 3.34%
1,723,160 $46.5 Million
Q2 2023

Aug 14, 2023

BUY
$13.33 - $25.53 $13.5 Million - $25.8 Million
1,009,626 Added 153.46%
1,667,523 $39.2 Million
Q1 2023

May 15, 2023

SELL
$13.49 - $18.72 $351,819 - $488,217
-26,080 Reduced 3.81%
657,897 $9.03 Million
Q4 2022

Feb 14, 2023

BUY
$14.47 - $18.17 $40,516 - $50,876
2,800 Added 0.41%
683,977 $12.4 Million
Q3 2022

Nov 14, 2022

BUY
$9.24 - $15.79 $3.56 Million - $6.08 Million
385,010 Added 130.0%
681,177 $10.2 Million
Q2 2022

Aug 15, 2022

SELL
$8.28 - $13.88 $1.25 Million - $2.09 Million
-150,460 Reduced 33.69%
296,167 $4.09 Million
Q1 2022

May 16, 2022

BUY
$11.18 - $24.02 $1.93 Million - $4.14 Million
172,305 Added 62.81%
446,627 $5 Million
Q4 2021

Feb 14, 2022

BUY
$20.95 - $26.88 $132,655 - $170,204
6,332 Added 2.36%
274,322 $6.5 Million
Q3 2021

Nov 16, 2021

BUY
$17.26 - $27.08 $4.63 Million - $7.26 Million
267,990 New
267,990 $6.84 Million

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.47B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.